Verastem, Inc. (VSTM)
5.82
+0.10
(+1.75%)
USD |
NASDAQ |
Mar 02, 15:08
Verastem EPS Diluted (Quarterly) : -1.347 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| ADMA Biologics, Inc. | 0.2025 |
| Zevra Therapeutics, Inc. | -0.0097 |
| Immuneering Corp. | -0.3772 |
| Tango Therapeutics, Inc. | 0.1431 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -98.52M |
| Revenue (Quarterly) | 11.24M |
| Total Expenses (Quarterly) | 109.76M |
| Enterprise Value | 382.60M |
| Gross Profit Margin (Quarterly) | 82.57% |
| Profit Margin (Quarterly) | -876.3% |
| Earnings Yield | -73.17% |
| Normalized Earnings Yield | -56.37 |